Inclusion criteria:
Patients participating in this trial are between 45 and 85 years old.
While taking the medication, Parkinson's disease was diagnosed with Hoehn and Yahr stage 2 to 4 criteria.
Patients must communicate clearly with staff and speak Persian.
Exclusion criteria:
Patients cannot have dopamine dis regulation syndrome or the presence of other neurological diseases such as major depression, dementia, attention deficit disorder, psychosis, or essential tremor.
Patients cannot have a history of epilepsy, traumatic brain injury, or brain surgery.
Patients cannot have severe sensory abnormalities of the fingertips, such as vibratory urticaria.
They were excluded from the study if they were currently using psychotropic or narcotic medications or taking medications that affect brain function that would alter recorded EEG activity (such as anticonvulsant, ADHD, depression, or anxiety medications).
Patients who are pregnant, lactating, or trying to become pregnant during the study period will be excluded from the study.
Also, according to the selected TUG task, patients should not have a history of multiple sclerosis (MS), Alzheimer's, hip fracture, total knee or hip replacement surgery, Huntington's disease, and a history of stroke.